Prognostic Significance of Tumor Response at the End of Therapy in Group III Rhabdomyosarcoma: A Report From the Children's Oncology Group

PURPOSE: Some patients with rhabdomyosarcoma (RMS) achieve less than a complete response (CR) despite receiving all planned therapy. We assessed the impact of best response at the completion of all therapy on patient outcome. PATIENTS AND METHODS: We studied 419 clinical group III participants who c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Rodeberg, David A., Stoner, Julie A., Hayes-Jordan, Andrea, Kao, Simon C., Wolden, Suzanne L., Qualman, Steve J., Meyer, William H., Hawkins, Douglas S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2009
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3020959/
https://ncbi.nlm.nih.gov/pubmed/19470937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.19.5933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados